87 related articles for article (PubMed ID: 34446148)
1. Characterization and Biological Evaluation of Solid Dispersed Nanoparticles of Synthetic Epoksilignan Targeting Pancreatic Cancer Cell as an Anticancer Agent.
Rifai Y; Tanggulungan W; Rahman L; Bhuyan DJ
J Biomed Nanotechnol; 2021 Jul; 17(7):1453-1458. PubMed ID: 34446148
[TBL] [Abstract][Full Text] [Related]
2. Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer.
Xu FG; Ma QY; Wang Z
Cancer Lett; 2009 Oct; 283(2):119-24. PubMed ID: 19232458
[TBL] [Abstract][Full Text] [Related]
3. Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies.
Freag MS; Elnaggar YS; Abdelmonsif DA; Abdallah OY
Int J Nanomedicine; 2016; 11():4799-4818. PubMed ID: 27703348
[TBL] [Abstract][Full Text] [Related]
4. Characterization, Antibacterial and Antioxidant Properties of Silver Nanoparticles Synthesized from Aqueous Extracts of
Otunola GA; Afolayan AJ; Ajayi EO; Odeyemi SW
Pharmacogn Mag; 2017 Jul; 13(Suppl 2):S201-S208. PubMed ID: 28808381
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis and Biological Evaluation of novel Hedgehog Inhibitors for treating Pancreatic Cancer.
Kumar V; Chaudhary AK; Dong Y; Zhong HA; Mondal G; Lin F; Kumar V; Mahato RI
Sci Rep; 2017 May; 7(1):1665. PubMed ID: 28490735
[TBL] [Abstract][Full Text] [Related]
6. Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide.
Trivino A; Gumireddy A; Meng F; Prasad D; Chauhan H
Drug Dev Ind Pharm; 2019 Aug; 45(8):1277-1291. PubMed ID: 31111732
[TBL] [Abstract][Full Text] [Related]
7. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
[TBL] [Abstract][Full Text] [Related]
8. Agents targeting the Hedgehog pathway for pancreatic cancer treatment.
Bisht S; Brossart P; Maitra A; Feldmann G
Curr Opin Investig Drugs; 2010 Dec; 11(12):1387-98. PubMed ID: 21154121
[TBL] [Abstract][Full Text] [Related]
9. Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and
Akhter MH; Kumar S; Nomani S
Drug Dev Ind Pharm; 2020 Apr; 46(4):659-672. PubMed ID: 32208984
[No Abstract] [Full Text] [Related]
10. Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications.
Ebadi M; Bullo S; Buskara K; Hussein MZ; Fakurazi S; Pastorin G
Sci Rep; 2020 Dec; 10(1):21521. PubMed ID: 33298980
[TBL] [Abstract][Full Text] [Related]
11. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
12. Anticancer activity of Ficus religiosa engineered copper oxide nanoparticles.
Sankar R; Maheswari R; Karthik S; Shivashangari KS; Ravikumar V
Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():234-9. PubMed ID: 25280701
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
Karavas E; Georgarakis E; Sigalas MP; Avgoustakis K; Bikiaris D
Eur J Pharm Biopharm; 2007 Jun; 66(3):334-47. PubMed ID: 17267194
[TBL] [Abstract][Full Text] [Related]
14. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
[TBL] [Abstract][Full Text] [Related]
15. Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process.
Won DH; Kim MS; Lee S; Park JS; Hwang SJ
Int J Pharm; 2005 Sep; 301(1-2):199-208. PubMed ID: 16024189
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of curcumin loaded chitosan/PEG blended PLGA nanoparticles for effective treatment of pancreatic cancer.
Arya G; Das M; Sahoo SK
Biomed Pharmacother; 2018 Jun; 102():555-566. PubMed ID: 29597089
[TBL] [Abstract][Full Text] [Related]
17. Structural characterization, antioxidant and anticancer properties of gold nanoparticles synthesized from leaf extract(decoction)of Antigonon leptopus Hook. &Arn.
Balasubramani G; Ramkumar R; Krishnaveni N; Pazhanimuthu A; Natarajan T; Sowmiya R; Perumal P
J Trace Elem Med Biol; 2015 Apr; 30():83-9. PubMed ID: 25432487
[TBL] [Abstract][Full Text] [Related]
18. Composition-dependent structural changes and antitumor activity of ASC-DP/DSPE-PEG nanoparticles.
Higashi K; Mibu F; Saito K; Limwikrant W; Yamamoto K; Moribe K
Eur J Pharm Sci; 2017 Mar; 99():24-31. PubMed ID: 27916697
[TBL] [Abstract][Full Text] [Related]
19. Formulation, characterization, and in vivo evaluation of celecoxib-PVP solid dispersion nanoparticles using supercritical antisolvent process.
Ha ES; Choo GH; Baek IH; Kim MS
Molecules; 2014 Dec; 19(12):20325-39. PubMed ID: 25486246
[TBL] [Abstract][Full Text] [Related]
20. Unusual anti-leukemia activity of nanoformulated naproxen and other non-steroidal anti-inflammatory drugs.
Kumar R; Siril PF; Javid F
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():1335-44. PubMed ID: 27612834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
